DESIGN AND DEVELOPMENT OFA 68GA/177LU-LABELED UNIVERSAL BOMBESIN PEPTIDE LIGAND FOR IMAGING AND THERAPY OF BOMBESIN RECEPTOR-EXPRESSING TUMORS

被引：0

作者：

Okarvi, S. M. ^{[1
]}

AlJammaz, I. ^{[1
]}

机构：

[1] King Faisal Specialist Hosp & Res Ctr, Cyclotron & Radiopharmaceut Dept, Riyadh 11211, Saudi Arabia

来源：

JOURNAL OF MOLECULAR NEUROSCIENCE | 2014年 / 53卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：S146 / S146

页数：1

共 45 条

[21] Development of a Neurotensin-Derived 68Ga-Labeled PET Ligand with High In Vivo Stability for Imaging of NTS1 Receptor-Expressing Tumors
Schindler, Lisa
Moosbauer, Jutta
Schmidt, Daniel
Spruss, Thilo
Graetz, Lukas
Luedeke, Steffen
Hofheinz, Frank
Meister, Sebastian
Echtenacher, Bernd
Bernhardt, Gunther
Pietzsch, Jens
Hellwig, Dirk
Keller, Max
CANCERS, 2022, 14 (19)
[22] Monomeric and Dimeric 68Ga-Labeled Bombesin Analogues for Positron Emission Tomography (PET) Imaging of Tumors Expressing Gastrin-Releasing Peptide Receptors (GRPrs)
Liolios, Christos
Buchmuller, Benjamin
Bauder-Wuest, Ulrike
Sohaefer, Martin
Leotta, Karin
Haberkorn, Uwe
Eder, Matthias
Kopka, Klaus
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (05) : 2062 - 2074
[23] The Dependence of Renal 68Ga[Ga]-DOTATOC Uptake on Kidney Function and Its Relevance for Peptide Receptor Radionuclide Therapy with 177Lu[Lu]-DOTATOC
Guehne, Falk
Heinzig, Alexander
Seifert, Philipp
Drescher, Robert
Freesmeyer, Martin
DIAGNOSTICS, 2021, 11 (07)
[24] [68Ga]Ga-ProBOMB5-a novel 68Ga-labeled [Leu13IPro14]bombesin analog for imaging gastrin-releasing peptide receptor expression with positron emission tomography
Wang, Lei
Kuo, Hsiou-Ting
Chapple, Devon
Colpo, Nadine
Zhang, Chengcheng
Wilson, Ryan
Benard, Francois
Lin, Kuo-Shyan
JOURNAL OF NUCLEAR MEDICINE, 2024, 65
[25] Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTA Octreotate for Somatostatin Receptor-expressing Neuroendocrine Tumors: The First US Experience
Delpassand, Ebrahim S.
Samarghandi, Amin
Zamanian, Sara
Erion, Jack
Somone, Jim
Wolfangel, Robert
Wolin, Edward M.
Espenan, Gregory D.
PANCREAS, 2013, 42 (02) : 373 - 373
[26] Design and development of the theranostic pair 177Lu-OPS201/68Ga-OPS202 for targeting somatostatin receptor expressing tumors
Mansi, Rosalba
Fani, Melpomeni
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 (10): : 635 - 645
[27] Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Patients With Somatostatin Receptor-Expressing Neuroendocrine Tumors The First US Phase 2 Experience
Delpassand, Ebrahim S.
Samarghandi, Amin
Zamanian, Sara
Wolin, Edward M.
Hamiditabar, Mohammadali
Espenan, Gregory D.
Erion, Jack L.
O'Dorisio, Thomas M.
Kvols, Larry K.
Simon, Jaime
Wolfangel, Robert
Camp, Arthur
Krenning, Eric P.
Mojtahedi, Alireza
PANCREAS, 2014, 43 (04) : 518 - 525
[28] 68Ga DOTATOC PET/CT for treatment response of Peptide Receptor Radionuclide Therapy using 177Lu and 90Y-DOTATOC
Finocchiaro, D.
Grassi, E.
Fioroni, F.
Castellani, G.
Lanconelli, N.
Versari, A.
Filice, A.
Iori, M.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S288 - S288
[29] Development of 68Ga-labeled [ Thz14]Bombesin(7-14) analogues for imaging gastrin-releasing peptide receptor expression with positron emission tomography
Wang, L.
Bratanovic, I.
Zhang, Z.
Merkens, H.
Colpo, N.
Zeisler, J.
Zhang, C.
Tan, R.
Wilson, R.
Benard, F.
Lin, K.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S97 - S98
[30] Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer
Richter, Susan
Wuest, Melinda
Krieger, Stephanie S.
Rogers, Buck E.
Friebe, Matthias
Bergmann, Ralf
Wuest, Frank
NUCLEAR MEDICINE AND BIOLOGY, 2013, 40 (08) : 1025 - 1034

← 1 2 3 4 5 →